Regular Blood Work After Gene Therapy Warranted by Rare Condition

(MedPage Today) -- Recipients of certain adeno-associated virus (AAV) vector-based gene therapies should be monitored closely for signs of thrombotic microangiopathy (TMA), FDA advisors agreed.
"Frequent laboratory assessments are necessary,...